← Back
Data updated: Mar 10, 2026
ESPERION THERAPS INC
Cardiovascular
ESPERION THERAPS INC is a pharmaceutical company focused on Cardiovascular. Key products include NEXLETOL.
2020
Since
2
Drugs
-
Trials
12
Approved (2yr)
Key Drugs
Recent Activity
NEXLIZET 2026-01-09
Labeling
NEXLETOL 2026-01-09
Labeling
NEXLIZET 2025-11-21
Efficacy
NEXLETOL 2025-11-21
Efficacy
NEXLIZET 2025-07-21
Labeling
NEXLIZET 2025-07-21
Labeling
NEXLETOL 2025-07-21
Labeling
NEXLETOL 2025-07-21
Labeling
NEXLIZET 2024-03-22
Efficacy
NEXLIZET 2024-03-22
Efficacy
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
2 drugs
Pipeline Strength Pro
Loading...